Evidence map›Paper›PMID 34810184›Full record

Observational studyBMJ open2021

Health care utilisation following childhood acute lymphoblastic leukaemia: a population-based matched cohort study.

Karen Schow Jensen, Birgitte Klug Albertsen, Henrik Schrøder, Alina Zalounina Falborg, Kjeld Schmiegelow, Steen Rosthøj, Michael Thude Callesen, Peter Vedsted

Registry-linked trialOpen access · goldAbstract readObservational Study
In one paragraph

Observational study in BMJ open, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT03985826 (Health Care Utilisation Following Childhood Acute Lymphoblastic Leukaemia), which is not on this map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
1.3field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT03985826 completednot on this map

Health Care Utilisation Following Childhood Acute Lymphoblastic Leukaemia: A Matched Cohort Study

TypeobservationalSponsorUniversity of AarhusRan2019 to 2019Enrolled7,348ConditionsPrecursor Cell Lymphoblastic Leukemia-LymphomaArmsDiagnosis of and treatment for Acute lymphoblastic leukaemia in childhood
3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 5 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 5 institutions in 1 country.

Karen Schow JensenDepartment of Paediatrics and Adolescent Medicine, Aarhus University Hospital, Aarhus, Denmark kascje@rm.dk.ORCID 0000-0002-0811-8818
Birgitte Klug AlbertsenDepartment of Paediatrics and Adolescent Medicine, Aarhus University Hospital, Aarhus, Denmark.
Henrik SchrøderDepartment of Paediatrics and Adolescent Medicine, Aarhus University Hospital, Aarhus, Denmark.
Alina Zalounina FalborgResearch Centre for Cancer Diagnosis in Primary Care, Research Unit for General Practice, Department of Public Health, Aarhus University, Aarhus, Denmark.
Kjeld SchmiegelowDepartment of Paediatrics and Adolescent Medicine, Copenhagen University Hospital, Copenhagen, Denmark.
Steen RosthøjDepartment of Paediatrics and Adolescent Medicine, Aalborg University Hospital, Aalborg, Denmark.
Michael Thude CallesenHans Christian Andersen Children's Hospital, Odense University Hospital, Odense, Denmark.
Peter VedstedResearch Centre for Cancer Diagnosis in Primary Care, Research Unit for General Practice, Department of Public Health, Aarhus University, Aarhus, Denmark.
Aarhus University Hospital · DKAarhus University · DKAalborg University Hospital · DKOdense University Hospital · DKUniversity of Copenhagen · DK

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectivesSurvival among children diagnosed with acute lymphoblastic leukaemia (ALL) has increased considerably. However, morbidity in survivors constitutes a potential increasing burden not limited to secondary health care. Our objectives were to compare health care utilisation, including both primary and secondary health care, between childhood ALL survivors and matched references up to 15 years after curative treatment. Moreover, to increase knowledge on survivors' health service seeking behaviour as time from treatment elapsed. DESIGN AND

settingA Danish population-based matched cohort study linking multiple nationwide registries.

participants675 cases, diagnosed with childhood (1.0-17.9 years) ALL between 1994 and 2015, and 6750 matched references sampled randomly from the source population (matched on age, gender and geographical region). PRIMARY OUTCOME MEASURES: Repeated consultations in general practice and hospital (outpatient and inpatient) estimated as yearly rates from 2.5 years after diagnosis and onwards. We compared cases and references with yearly incidence rate ratios (IRRs) from negative binomial regression models.

resultsSurvivors of childhood ALL had a mean number of yearly daytime contacts in general practice of 4.75 (95% CI 4.41 to 5.11) the first year, corresponding to an IRR of 1.85 (95% CI 1.71 to 2.00); decreasing to 1.16 (1.01 to 1.34) after 15 years, and without significant impact of gender (p=0.894) or age (p=0.399). For hospital contacts, ALL survivors had a mean number of yearly contacts of 14.21 (13.38-15.08) the first year, corresponding to an IRR of 31.50 (28.29-35.07); decreasing to 2.42 (1.59-3.68) after 15 years. No differences were found across calendar time.

conclusionsALL survivors used significantly more health care services across sectors than the reference population. Decreasing use over 15 years illustrated the dynamics of health care needs; this knowledge may inform the future organisation of integrated follow-up programmes. TRIAL REGISTRATION NUMBER: NCT03985826.

Indexed as

Precursor Cell Lymphoblastic Leukemia-LymphomaSurvivorsChildCohort StudiesHumansIncidencePatient Acceptance of Health Careepidemiologyleukaemiapaediatric oncologyprimary care

Identifiers

PMID34810184
PMCPMC8609931
OpenAlexW3216237766

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.